CASP3 and Parkinson disease: We investigated HSYA’s effect on the degeneration of PD-associated dopaminergic neuronal cells and characterised its implication at the molecular level in neuronal cell inflammation and apoptosis through the MAPK and cytochrome C/caspase-3 signalling pathways, respectively.